Roger P.
- Country
- Spain
- Department
- Infectious diseases
Research Overview
- Evaluation of Abatacept and Placebo in Hospitalized Adults with COVID-19: A Randomized, Controlled Trial on Immune Modulation Strategies
- A Phase 3, Randomized, Active-Controlled, Double-Blind Clinical Study to Evaluate the Antiretroviral Activity, Safety, and Tolerability of Doravirine/Islatravir (DOR/ISL 100 mg/0.25 mg) Once-Daily in HIV-1 Infected Treatment-Naïve Participants
- Evaluation of Anti-SARS-CoV-2 Polyclonal Hyperimmune Globulin Efficacy and Safety in Early-Stage COVID-19 Adult Outpatients: A Randomized, Double-Blind, Placebo-Controlled Trial
Data & Insights
Has run more than one trial at 61 of 190 partner sites.
Specializations
Infectious Disease Management
This investigator specializes in treating COVID-19 patients, with particular emphasis on outpatient care and therapeutic interventions for high-risk individuals.
- Viral Infection Treatment
- Outpatient Care Protocols
- High-Risk Patient Management
The research focus includes evaluating novel therapeutic approaches for reducing hospitalization risks and improving outcomes in COVID-19 patients.
Therapeutic Development
The investigator conducts research in antiviral therapeutics, specifically examining new treatment options for respiratory viral infections in outpatient settings.
- Novel Drug Evaluation
- Treatment Efficacy Assessment
- Safety Protocol Development
Their work encompasses the evaluation of supportive care strategies alongside experimental treatments.
Clinical Outcomes Research
Specialized focus on mortality prevention and reduction of hospitalization rates among infectious disease patients.
- All-cause Mortality Studies
- Hospitalization Prevention
- Risk Factor Analysis
The investigator examines interventions aimed at improving survival rates and reducing healthcare burden.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.